Acceptability of Percutaneous InterventionsAccept_scaleNCT07380100
Development of a Patient-reported Scale to Assess the Acceptability of Percutaneous Physiotherapy Interventions: a Modified Delphi Study
An observational study of Acceptability of Percutaneous Interventions, run by Universidad de Zaragoza at 1 site in Spain.
Trial summary
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Acceptability of Percutaneous Interventions
- What is being tested?
- Iterative focus group sessions and individual evaluation phases
- How many people
- 21 participants
- Where
- 1 siteSpain
- Study dates
- 1 Apr 2025to 23 Mar 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Experts in percutaneous interventions and pain management
Experts were required to:
- have at least five years of experience in percutaneous techniques
- have clinical experience working with patients with pain
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Read the detailed description
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
- Being tested
- Iterative focus group sessions and individual evaluation phases
- Keywords
- Acceptability, Scale, Percutaneous Interventions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Iterative focus group sessions and individual evaluation phasesOther
The expert panel conducted iterative focus group sessions and successive individual evaluation phases until consensus was reached on the development of the acceptability scale.
| Study group | Role | What they receive |
|---|---|---|
| Experts Panel | 21 experts (4 women and 17 men) took part in the study. The expert panel consisted of 14 physiotherapists, 3 psychologists, and 3 physicians Receives: Other: Iterative focus group sessions and individual evaluation phases |
What is being measured
The primary outcome is the main question the study is designed to answer.
Consensus among the experts
Consensus must be achieved among the experts panel to establish final decisions on the acceptability scale development.
Measured: Consensus will be achieved through 5 evaluation phases: Day 1 and Day 7 after firstand second, respectively, focus group sessions Month 1, 2, 3, 4, and 5, after each individual evaluation round
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Feb 2026
- Study start1 Apr 2025
- Primary completion28 Feb 2026
- Study completion23 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acceptability of Percutaneous InterventionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad de Zaragoza
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alberto Carcasona Otal, Universidad de Zaragoza
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07380100
- Sponsor's protocol ID
- Acceptability Scale
- Acronym
- Accept_scale
- Status last verified
- Sep 2026
- First submitted
- 13 Jan 2026
- Last updated
- 17 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.
Study at a glance
From the registry record, last updated by the sponsor on 17 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of a Patient-reported Scale to Assess the Acceptability of Percutaneous Physiotherapy Interventions: a Modified Delphi Study
- ClinicalTrials.gov ID
- NCT07380100
- Acronym / sponsor ID
- Accept_scale / Acceptability Scale
- Keywords
- Acceptability, Scale, Percutaneous Interventions
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 21 participants (actual)
- Lead sponsor
- Universidad de ZaragozaUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 28 Feb 2026 (actual)
- Study completion
- 23 Mar 2026 (actual)
- First posted
- 2 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Detailed description
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions. A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management. The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received. The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experts Panel | – | Other: Iterative focus group sessions and individual evaluation phases21 experts (4 women and 17 men) took part in the study. The expert panel consisted of 14 physiotherapists, 3 psychologists, and 3 physicians |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Experts in percutaneous interventions and pain management
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Iterative focus group sessions and individual evaluation phasesThe expert panel conducted iterative focus group sessions and successive individual evaluation phases until consensus was reached on the development of the acceptability scale. | Other | Experts Panel |
Primary outcome
Consensus among the experts
Time frame: Consensus will be achieved through 5 evaluation phases: Day 1 and Day 7 after firstand second, respectively, focus group sessions Month 1, 2, 3, 4, and 5, after each individual evaluation round
Consensus must be achieved among the experts panel to establish final decisions on the acceptability scale development.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Sep 2026.
- Individual participant dataSharing planned: Yes. Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acceptability of Percutaneous Interventions, run by Universidad de Zaragoza at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Consensus among the experts (time frame: Consensus will be achieved through 5 evaluation phases: Day 1 and Day 7 after firstand second, respectively, focus group sessions Month 1, 2, 3, 4, and 5, after each individual evaluation round). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.